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There is a substantial gap between the levels of enzyme activity that nature can achieve and those that 
scientists can evolve in the lab. This suggests that conventional directed evolution techniques involving 
incremental improvements in enzyme activity may frequently fail to ascend even local fitness maxima. This is 
most likely due to the difficulty for step-wise evolutionary approaches in effectively retaining mutations that are 
beneficial in combination with one another, but on an individual basis are neutral or deleterious (i.e., exhibit 
positive epistasis). We sought to determine whether a superior enzyme identified using a simultaneous mass 
site directed mutagenesis approach could have been identified using a step-wise approach. We conducted 
simultaneous mass randomisation of eight key active site residues in Escherichia coli NfsA, a nitroreductase 
enzyme that has diverse applications in biotechnology. Using degenerate codons, we generated a diverse 
library containing 394 million unique variants. We then applied a powerful positive selection using 
chloramphenicol which is toxic to E. coli but can be detoxified via nitro-reduction. This has enabled us to recover 
a diverse range of highly active nitroreductase variants. For two of the most active variants, we have created all 
possible combinations of single mutations. This allowed us to examine whether a step-wise mutagenesis 
pathway could have also yielded these enzymes. As anticipated, we identified complex epistatic interactions 
between residues in these enzyme variants. We have also investigated the “black-box” effect of enzyme 
engineering, examining the consequences that evolving NfsA towards one specialist activity had on the other 
promiscuous activities of NfsA. Variants generated in this study have also had practical applications, in 
particular for targeted cell ablation in zebrafish. We have identified NfsA variants that are highly active with nil-
bystander prodrugs that can selectively ablate nitroreductase expressing cells without harm to adjacent cells. In 
ongoing work, our lead variants are being evaluated for their utility in transgenic zebrafish models of 
degenerative disease.  
 
 
